Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), the advertising technology platform powered by unique data and media, today...
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Oncology Devices Market Report 2026" has been added to ResearchAndMarkets.com's offering.The oncology devices market has witnessed significant...
-
Highly comparable biodistribution profiles of Radio-DARPin candidates labeled with imaging isotopes 177Lu or 203Pb allows for rapid expansion of pipeline with multiple therapeutic isotopes ...
-
Initiated US Phase 1/2a study of DLL3-targeting 212Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed with strategic partner Orano Med; initial data...
-
Expanded into AI-resilient growth channels through enhanced mobile in-app capabilities and the release of Nexxen’s industry-first programmatic Smart TV home screen ad activation solution, which is now...
-
NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and...